Protalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2025 Earnings Call Transcript August 14, 2025
Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Second Quarter 2025 Financial and Business Results Conference Call. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Mike Moyer, with LifeSci Advisors. You may begin your conference.
Mike Moyer: Thank you, operator, and welcome to the Protalix BioTherapeutics...
